08/03/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 8/3/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Poplar SARS-CoV-2 TMA Pooling assay. The Poplar SARS-CoV-2 TMA Pooling assay is authorized for use with certain respiratory specimens collected from individuals who are suspected of COVID-19 by their healthcare provider. (PDF)
.png)
No hay comentarios:
Publicar un comentario